Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Current Medicinal Chemistry|February 7, 2003
Recent advances in peroxisome proliferator-activated receptor scienceBarry G Shearer, William J HoekstraBiochimica Et Biophysica Acta|July 3, 2007
The next generation of PPAR drugs: do we have the tools to find them?Barry G Shearer, Andrew N BillinOrganic Letters|February 1, 2002
A novel method for the generation of nitrile oxides on solid phase: application to the synthesis of substituted benzopyranoisoxazolesEsther Y Chao, Douglas J Minick, Daniel D Sternbach, et al.Bioorganic & Medicinal Chemistry|March 27, 2018
2,4-Diamino-8-quinazoline carboxamides as novel, potent inhibitors of the NAD hydrolyzing enzyme CD38: Exploration of the 2-position structure-activity relationshipsDavid N Deaton, Curt D Haffner, Brad R Henke, et al.Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Synthesis and evaluation of potent and selective beta3 adrenergic receptor agonists containing heterobiaryl carboxylic acidsBarry G Shearer, Esther Y Chao, David E Uehling, et al.Molecular Endocrinology (Baltimore, Md.)|November 3, 2007
Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonistBarry G Shearer, David J Steger, James M Way, et al.Journal of Medicinal Chemistry|April 29, 2005
Identification and structure-activity relationship of phenolic acyl hydrazones as selective agonists for the estrogen-related orphan nuclear receptors ERRbeta and ERRgammaWilliam J Zuercher, Stéphanie Gaillard, Lisa A Orband-Miller, et al.Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Discovery of a novel class of PPARdelta partial agonistsBarry G Shearer, Hari S Patel, Andrew N Billin, et al.Bioorganic & Medicinal Chemistry Letters|May 30, 2007
Co-crystal structure guided array synthesis of PPARgamma inverse agonistsRyan P Trump, Jeffrey E Cobb, Barry G Shearer, et al.Journal of Medicinal Chemistry|February 5, 2010
Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonistBarry G Shearer, Robert W Wiethe, Adam Ashe, et al.Pageof 2